Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes

OBJECTIVE: Serum concentrations of the hepatokine fibroblast growth factor (FGF) 21 are elevated in obesity, type-2 diabetes, and the metabolic syndrome. We asked whether FGF21 levels differ between subjects with metabolically healthy vs. unhealthy obesity (MHO vs. MUHO), opening the possibility tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Berti, Lucia, Irmler, Martin, Zdichavsky, Marty, Meile, Tobias, Böhm, Anja, Stefan, Norbert, Fritsche, Andreas, Beckers, Johannes, Königsrainer, Alfred, Häring, Hans-Ulrich, de Angelis, Martin Hrabě, Staiger, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481465/
https://www.ncbi.nlm.nih.gov/pubmed/26137439
http://dx.doi.org/10.1016/j.molmet.2015.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481465/
https://www.ncbi.nlm.nih.gov/pubmed/26137439
http://dx.doi.org/10.1016/j.molmet.2015.04.002

Ejemplares similares